Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 3, 1999, Pages 680-688

  Obrosova, Irina G ^a,b   Stevens, Martin J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Division of Metabolism Endocrinology and Diabetes   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MALONALDEHYDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATARACT; CATARACTOGENESIS; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; ENERGY METABOLISM; ENZYME INHIBITION; GLUCOSE UTILIZATION; GLYCOLYSIS; LENS EPITHELIUM; NONHUMAN; OSMOTIC STRESS; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; STREPTOZOCIN DIABETES;

ADENOSINE TRIPHOSPHATE; ANIMALS; CATARACT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, EXPERIMENTAL; DIETARY SUPPLEMENTS; ENERGY METABOLISM; GLUTATHIONE; HEXOSES; LENS, CRYSTALLINE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NADP; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; SUGAR ALCOHOLS; TAURINE;

EID: 0033010213     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Kinoshita JH, Merola LO, Satoh K, Dikmak E. Osmotic changes caused by the accumulation of dulcitol in the lenses of rats fed with galactose. Nature. 1962;194:1085-1087.
2. Dvornik E, Simard-Duquesne N, Krami M, et al. Polyol accumulation in galactosemic and diabetic rats: control by an aldose reductase inhibitor. Science. 1973;182:1146-1148.
3. Varma SD, Kinoshita JH. The absence of cataracts in mice with congenital hyperglycemia. Exp Eye Res. 1974;19:577-582.
4. Chylack LT Jr, Henriques HF, Tung WH. Inhibition of sorbitol production in human lenses by an aldose reductase inhibitor. Doc Ophthalmol Proc Series. 1979;18:65-75.
5. Kador PF, Akagi Y, Kinoshita JH. Diabetic cataracts in animal models: prevention and reversibility with aldose reductase inhibitors. Diabet Med. 1985;2:194-196.
6. Lee AYW, Chung SK, Chung SM. Demonstration that polyol accumulation is responsible for diabetic cataracts by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc Natl Acad Sci USA. 1995;92:2780-2784.
7. Robison WG Jr, Laver NM, Jacot JL, et al. Diabetic-like retinopathy ameliorated with the aldose reductase inhibitor WAY-121,509. Invest Ophthalmol Vis Sci. 1996;37:1149-1156.
8. Datiles MB, Fukui H. Cataract prevention in diabetic Octodon degus with Pfizer's sorbinil. Curr Eye Res. 1989;8:233-237.
9. Sato S, Mori K, Wyman M, Kador PF. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175. Exp Eye Res. 1998;66:217-222.
10. Beyer-Mears A, Bucci FA Jr, Del Val M, Cruz E. Dietary myo-inositol effect on sugar cataractogenesis. Pharmacology. 1989;39:59-68.
11. Ruf JC, Ciavatti M, Gustafsson T, Renaud S. Effect of D-myo-inositol on platelet function and on cataract development in streptozotocin-induced diabetic rats. Biachem Med Metab Biol. 1992;48:46-55.
12. Trevithick JR, Mitton KP, Kilic F, Bhardwaj R, Caulfield J. Modelling cortical cataractogenesis: does model diabetic rat cataract early loss of taurine and amino acids decrease lens antioxidant activity? (Abstract). Exp Eye Res. 1998;67(suppl 1):S2.
13. Malone JI, Benford SA, Malone J Jr. Taurine prevents galactose-induced cataracts J Diabetes Complications. 1993;7:44-48.
14. Devamanoharan PS, Ali A, Varma SD. Oxidative stress to rat lens in vitro: attenuation by taurine [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1997;38(4):S1025. Abstract nr 4775.
15. Trachtman H, Futterweit S, Maesaka J, et al. Taurine ameliorates chronic streptozotocin-induced diabetic nephropathy in rats. Am J Physiol. 1995;269(pt 2):F429-F438.
16. Reddy DVN. Distribution of free amino acids and related compounds in ocular fluids, lens and plasma of various animals. Infest Ophthalmol. 1968;6:478-483.
17. Mitton KP, Hess JL, Bunce GE. Free amino acids reflect impact of selenite-dependent stress on primary metabolism in rat lens. Curr Eye Res. 1997;16:997-1005.
18. Baskin SI, Cohn EM, Kocsis JJ. Taurine changes in visual tissues with age. In: Huxtable R, Barbeau A, eds. Taurine. New York: Raven Press; 1976:201-208.
19. Malone JI, Lowitt S, Cook WR. Nonosmotic diabetic cataracts. Pediatr Res. 1990;27:293-296.
20. Reddy VN, Lin LR, Giblin FJ, Chakrapani B, Yokoyama T. Study of the polyol pathway and cell permeability changes in human lens and retinal pigment epithelium in tissue culture. Invest Ophthalmol Vis Sci. 1992;33:2334-2339.
21. Lou MF, Dickerson JE Jr, Garadi R, York BM Jr Glutathione depletion in the lens of galactosemic and diabetic rats. Exp Eye Res. 1988;46:517-530.
22. Mitton KP, Trevithick JR. High-performance liquid chromatography-electrochemical detection of antioxidants in vertebrate lens: glutathione, tocopherol, and ascorbate. Methods Enzymol. 1994; 233:523-539.
23. Stevens MJ, Henry DN, Thomas TP, Killen PD, Greene DA. Aldose reductase gene expression and osmotic dysregulation in cultured human retinal pigment epithelial cells. Am J Physiol. 1993;265(pt 1):E428-E438.
24. Burg MB. Molecular basis of osmotic regulation. Am J Physiol. 1995;268(pt 2):F983-F996.
25. Morimura H, Shimada S, Otori Y, et al. The differential osmoregulation and localization of taurine transporter mRNA and Na+/myo-inositol cotransporter mRNA in rat eyes. Brain Res Mol Brain Res. 1997;44:245-252.
26. Stevens MJ, Lattimer SA, Kamijo M, Van Huysen C, Sima AA, Greene DA. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Diabetologia. 1993;36:608-614.
27. Schuller-Levis GB, Gordon RE, Park E, Pendino KJ, Laskin DL. Taurine protects rat bronchioles from acute ozone-induced lung inflammation and hyperplasia. Exp Lung Res. 1995;21:877-888.
28. Son M, Kim HK, Kim WB, Yang J, Kim BK. Protective effect of taurine on indomethacin-induced gastric mucosal injury. Adv Exp Med Biol. 1996;403:147-155.
29. Lowry OH, Passonneau JV. A Flexible System of Enzymatic Analysis. Orlando: Academic Press; 1972.
30. Bergmeyer HU, Gruber W, Gutmann I. D-Sorbitol. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. Deerfield, FL: Weinheim Verlag Chemie; 1974:1323-1330.
31. Holmes EW. Coupled enzymatic assay for the determination of sucrose. Anal Biochem. 1997;244:103-109.
32. Weissbach A. myo-Inositol. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. Deerfield, FL: Weinheim Verlag Chemie; 1974:1333-1336.
33. Jones BN, Paabo S, Stein S. Amino acid analysis and enzymatic sequence determination of peptides by an improved o-phthaldialdehyde precolumn labeling procedure. J Liq Chromat. 1981;4: 565-586.
34. Mokrasch LC, Teschke EJ. Glutathione content of cultured cells and rodent brain regions: a specific fluorometric assay. Anal Biochem. 1984;140:506-509.
35. Williamsun DH, Lund P, Krebs HA. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J. 1967;103:514-527.
36. Veech RL, Eggleston LV, Krebs HA. The redox state of free nicotinamide-adenine nucleotide phosphate in the cytoplasm of rat liver. Biochem J. 1969;103:514-527.
37. Masuda T, Dobson GP, Veech RL. The Gibbs-Donnan near-equilibrium system of heart. J Biol Chem. 1990;265:20321-20334.
38. Lal S, Szwergold BS, Taylor AH, et al. Metabolism of fructose-3-phosphate in the diabetic rat lens. Arch Biochem Biophys. 1995; 318:191-199.
39. Cameron NE, Cotter MA, Basso M, Hohman TC. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia. 1997;40:271-281.
40. Heinamaki AA, Muhonen ASH, Piha RS. Taurine and other free amino acids in the retina, vitreous, lens, iris-ciliary body, and cornea of the rat eye Neurochem Res. 1986;11:535-542.
41. Vilchis C, Salceda R. Effect of diabetes on levels and uptake of putitative amino acid neurotransmitters in rat retina and retinal pigment epithelium. Neurochem Res. 1996;21:1167-1171.
42. Beyer-Mears A, Cruz E. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor. Diabetes. 1985;34:15-21.
43. 3H]-myo-inositol incorporation into the phosphoinositide cycle in bovine lens epithelial cells in vitro. Curr Eye Res. 1990; 9:561-568.
44. Reeves RE, Cammarata PR. Osmoregulatory alterations in myoinositol uptake by bovine lens epithelial cells. Pt 5: mechanisms of the myo-inositol efflux pathway. Invest Ophthalmol Vis Sci. 1996; 37:619-629.
45. Geissen K, Utz R, Grotsch H, Lang J, Nimmesgern H. Sorbitolaccumulating pyrimidine derivatives. Arzneim-Forsch/Drug Res. 1994;44:1032-1043.
46. Obrosova I, Burgan J, Ostrow E, Oates P. Evaluation of structurally different ARIs vs SDI on diabetes-induced changes in lens metabolism [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1997;38(4): S1171. Abstract nr 5450.
47. Hothersall JS, Taylaur CE, McLean P. Antioxidant status in an in vitro model for hyperglycemic lens cataract formation: effect of aldose reductase inhibitor statil. Biochem Med Metab Biol. 1988; 40:109-117.
48. Lou MF, Dickerson JE Jr, Chandler ML, Brazzell RK, York BM Jr. The prevention of biochemical changes in lens, retina and nerve of galactosemic dogs by the aldose reductase inhibitor ALO1576. J Ocul Pharmacol. 1989;5:233-240.
49. Maitra I, Scrbinova E, Trischler HJ, Packer L. Stereospecific effects of R-lipoic acid on buthionine sulfoximine-induced cataract formation in newborn rats. Biochem Biophys Res Commun. 1996;221: 422-429.
50. Raschke P, Massoudy P, Becker BF. Taurine protects the heart from neutrophil-induced reperfusion injury. Free Radic Biol Med. 1995; 19:461-471.
51. Gumuslu S, Yucel G, Aydin M, Yesilkaya A, Demir AY, Aksu TA. The role of antioxidants in the prevention of t-butyl hydroperoxide-induced chemiluminescence. Int J Clin Lab Res. 1996;26:119-123.
52. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J. 1988;256:251-255.
53. Shi X, Flynn DC, Porter DW, Leonard SS, Vallyathan V, Castranova V. Efficacy of taurine based compounds as hydroxyl radical scavengers in silica induced peroxidation. Ann Clin Lab Sci. 1997;27: 365-374.
54. Yan LJ, Traber MG, Kobuchi H, Matsugo S, Trischler HJ, Packer L. Efficacy of hypochlorous acid scavengers in the prevention of protein carbonyl formation. Arch Biochem Biophys. 1996;327: 330-334.
55. Dudina El, Formaziuk VE, Sergienko VI, Gorshkova TN. Interaction of various amino acids, dipeptides and glutathionc with hypochlorite anion (CIO-). Vestnik Rossiiskoi Akademii Meditsinskikh Nauk. 1995;3:31-33.
56. Liukova TV, Formaziuk VE, Kachina NN, Petrunin DD, Sergienko VI. Detection of mycloperoxidase in eye tissues of man. Biulleten Eksperimentalnoi Biologii I Meditsiny. 1990;109:557-558.
57. Chanine R, Feng J. Protective effects of taurine against reperfusion-induced arrhythmias in isolated ischemic rat heart. Arzneimittel-forschung. 1998;48:360-364.
58. Giblin FJ, Chakrapani B, Reddy VN. The effects of X-radiation on lens reducing systems. Invest Ophthalmol Vis Sci. 1979;18:468-475.
59. 2 and photochemically induced cataract. Curr Eye Res. 1993; 12:163-179.
60. Vivekanandan S, Lou MF. Evidence for the presence of phosphoinositide cycle and its involvement in cellular signal transduction in the rabbit lens. Curr Eye Res. 1989;8:101-111.
61. Gonzalez AM, Sochor M, McLean P. The effect of an aldose reductase inhibitor (sorbinil) on the level of metabolites in lenses of diabetic rats. Diabetes. 1983;32:482-485.
62. Cheng HM, Gonzalez RG, von Saltza I, Chylack LT Jr, Hutson NJ. Glucose flux and the redox state of pyridine nucleotides in the rat lens. Exp Eye Res. 1988;46:947-952.
63. Varma SD, Kinoshita JH. Sorbitol pathway in diabetic and galactosemic rat lens Biochim Biophys Acta. 1974;338:632-6-40.
64. Obrosova I, Oates P, Nakano T, Petrash JM. Gtycolytic pathway, redox state of NAD-couples and energy metabolism in lens in rats with short-term streptozotocin diabetes (Abstract). Diabetes. 1996;45(suppl 2):195A.
65. Obrosova I, Cao X, Greene D, Stevens M. Diabetes-induced changes in lens antioxidant status, glucose utilization and energy metabolism: effect of DL-α-lipoic acid. Diabetologia. 1998;41: 1442-1450.
66. 31P-nuclear magnetic resonance evidence of an activated hexosemonophosphate shunt in hyperglycemic rat lenses in vivo Diabetes. 1995;44:810-815.
67. Lehninger AL. Electron transport, oxidative phosphorylation, and regulation of ATP production. In: Lehninger AL, ed. Principles of Biochemistry. New York: Worth Publishers; 1987:467-510.
68. Gonzalez AM, Sochor M, Hothersall JS, McLean P. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in the diabetic rat lens. Diabetes. 1986;35:1200-1205.
69. Yen LA, Ashton MA. The increase in lipid peroxidation in diabetic rat lens can be reversed by oral sorbinil. Metabolism. 1990;39: 619-622
70. Obrosova I, Faller A, Burgan J, Ostrow E, Williamson J. Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor. Curr Eye Res. 1997;16:34-43.